Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving leading biopharmaceutical companies globally:

McKinsey
McKesson
Harvard Business School
Colorcon
Boehringer Ingelheim
Moodys

Last Updated: October 15, 2019

DrugPatentWatch Database Preview

Amphastar Pharm Company Profile

See Plans and Pricing

« Back to Dashboard

What is the competitive landscape for AMPHASTAR PHARM, and what generic and branded alternatives to AMPHASTAR PHARM drugs are available?

AMPHASTAR PHARM has eleven approved drugs.



Summary for Amphastar Pharm
US Patents:0
Tradenames:10
Ingredients:9
NDAs:11
Patent Litigation for Amphastar Pharm: See patent lawsuits for Amphastar Pharm

Drugs and US Patents for Amphastar Pharm

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Amphastar Pharm KETOROLAC TROMETHAMINE ketorolac tromethamine INJECTABLE;INJECTION 076209-002 Jul 21, 2004 AP RX No No   See Pricing   See Pricing
Amphastar Pharms Inc MEDROXYPROGESTERONE ACETATE medroxyprogesterone acetate INJECTABLE;INJECTION 077235-001 Nov 28, 2017 AB RX No No   See Pricing   See Pricing
Amphastar Pharms Inc SODIUM NITROPRUSSIDE sodium nitroprusside INJECTABLE;INJECTION 209832-001 Dec 18, 2017 AP RX No No   See Pricing   See Pricing
Amphastar Pharms Inc NEOSTIGMINE METHYLSULFATE neostigmine methylsulfate SOLUTION;INTRAVENOUS 209933-001 Sep 25, 2017 AP RX No No   See Pricing   See Pricing
Amphastar Pharm ENOXAPARIN SODIUM (PRESERVATIVE FREE) enoxaparin sodium INJECTABLE;SUBCUTANEOUS 076684-006 Sep 19, 2011 AP RX No No   See Pricing   See Pricing
Amphastar Pharms Inc MEDROXYPROGESTERONE ACETATE medroxyprogesterone acetate INJECTABLE;INJECTION 077334-001 Nov 28, 2017 AB RX No No   See Pricing   See Pricing
Amphastar Pharms Inc ISOPROTERENOL HYDROCHLORIDE isoproterenol hydrochloride INJECTABLE;INJECTION 210106-001 Jun 18, 2018 AP RX No No   See Pricing   See Pricing
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Dow
Express Scripts
Baxter
McKinsey
Moodys

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.